Nutri Pharmaceuticals Research Inc
Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its "oil to powder' products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and org… Read more
Market Cap & Net Worth: Nutri Pharmaceuticals Research Inc (NRPR)
Nutri Pharmaceuticals Research Inc (PINK:NRPR) has a market capitalization of $2.21 Million ($2.21 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49689 globally and #15184 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nutri Pharmaceuticals Research Inc's stock price $0.02 by its total outstanding shares 105310324 (105.31 Million).
Nutri Pharmaceuticals Research Inc Market Cap History: 2015 to 2025
Nutri Pharmaceuticals Research Inc's market capitalization history from 2015 to 2025. Data shows growth from $789.83K to $2.21 Million (13.22% CAGR).
Nutri Pharmaceuticals Research Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nutri Pharmaceuticals Research Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NRPR by Market Capitalization
Companies near Nutri Pharmaceuticals Research Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Nutri Pharmaceuticals Research Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Nutri Pharmaceuticals Research Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nutri Pharmaceuticals Research Inc's market cap moved from $789.83K to $ 2.21 Million, with a yearly change of 13.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.21 Million | +31.25% |
| 2024 | $1.68 Million | 0.00% |
| 2023 | $1.68 Million | -52.94% |
| 2022 | $3.58 Million | +13.33% |
| 2021 | $3.16 Million | +322.54% |
| 2020 | $747.70K | +16.39% |
| 2019 | $642.39K | -23.75% |
| 2018 | $842.48K | +33.33% |
| 2017 | $631.86K | 0.00% |
| 2016 | $631.86K | -20.00% |
| 2015 | $789.83K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nutri Pharmaceuticals Research Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.21 Million USD |
| MoneyControl | $2.21 Million USD |
| MarketWatch | $2.21 Million USD |
| marketcap.company | $2.21 Million USD |
| Reuters | $2.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.